[go: up one dir, main page]

WO2010015709A3 - Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung - Google Patents

Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung Download PDF

Info

Publication number
WO2010015709A3
WO2010015709A3 PCT/EP2009/060293 EP2009060293W WO2010015709A3 WO 2010015709 A3 WO2010015709 A3 WO 2010015709A3 EP 2009060293 W EP2009060293 W EP 2009060293W WO 2010015709 A3 WO2010015709 A3 WO 2010015709A3
Authority
WO
WIPO (PCT)
Prior art keywords
active ingredients
fibrous surface
surface structure
containing active
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/060293
Other languages
English (en)
French (fr)
Other versions
WO2010015709A2 (de
Inventor
Burghard Liebmann
Evgueni Klimov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Priority to CN2009801397720A priority Critical patent/CN102176905A/zh
Priority to EP09781627A priority patent/EP2323635A2/de
Priority to US13/058,033 priority patent/US20110129510A1/en
Priority to JP2011521595A priority patent/JP2011530661A/ja
Publication of WO2010015709A2 publication Critical patent/WO2010015709A2/de
Publication of WO2010015709A3 publication Critical patent/WO2010015709A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Artificial Filaments (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nonwoven Fabrics (AREA)

Abstract

Die Erfindung betrifft wirkstoffhaltige Faserflächengebilde mit einstellbarem Wirkstofffreisetzungsprofil, umfassend einen faserförmigen, polymeren löslichen und/oder abbaubaren Wirkstoffträger und wenigstens einen mit dem Träger assoziierten und von dem Faserflächengebilde freisetzbaren Wirkstoff; wirkstoffhaltige Formulierungen, umfassend solche Faserflächengebilde; die Verwendung erfindungsgemäßer wirkstoffhaltiger Faserflächengebilde zur Herstellung wirkstoffhaltiger Formulierungen; und Verfahren zur Herstellung erfindungsgemäßer Faserflächengebilde.
PCT/EP2009/060293 2008-08-08 2009-08-07 Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung Ceased WO2010015709A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2009801397720A CN102176905A (zh) 2008-08-08 2009-08-07 具有受控释放的活性成分的含活性成分的纤维层状结构，其用途及其生产方法
EP09781627A EP2323635A2 (de) 2008-08-08 2009-08-07 Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung
US13/058,033 US20110129510A1 (en) 2008-08-08 2009-08-07 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof
JP2011521595A JP2011530661A (ja) 2008-08-08 2009-08-07 活性成分の制御放出を伴う有効成分含有繊維表面構造体、その使用、およびその生産のための方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08162122.9 2008-08-08
EP08162122 2008-08-08

Publications (2)

Publication Number Publication Date
WO2010015709A2 WO2010015709A2 (de) 2010-02-11
WO2010015709A3 true WO2010015709A3 (de) 2010-10-21

Family

ID=41510935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/060293 Ceased WO2010015709A2 (de) 2008-08-08 2009-08-07 Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung

Country Status (5)

Country Link
US (1) US20110129510A1 (de)
EP (1) EP2323635A2 (de)
JP (1) JP2011530661A (de)
CN (1) CN102176905A (de)
WO (1) WO2010015709A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040260034A1 (en) 2003-06-19 2004-12-23 Haile William Alston Water-dispersible fibers and fibrous articles
US7892993B2 (en) 2003-06-19 2011-02-22 Eastman Chemical Company Water-dispersible and multicomponent fibers from sulfopolyesters
US8513147B2 (en) 2003-06-19 2013-08-20 Eastman Chemical Company Nonwovens produced from multicomponent fibers
WO2008155304A1 (de) * 2007-06-20 2008-12-24 Basf Se Synthetische repetitive proteine, deren herstellung und verwendung
WO2010015419A2 (de) * 2008-08-08 2010-02-11 Basf Se Wirkstoffhaltige fasernflächengebilde auf basis von biopolymeren, ihre anwendungen und verfahren zu ihrer herstellung
US8512519B2 (en) 2009-04-24 2013-08-20 Eastman Chemical Company Sulfopolyesters for paper strength and process
DE102010012845A1 (de) * 2010-03-25 2011-09-29 Carl Freudenberg Kg Durch Rotationsspinnverfahren hergestellte Mehrkomponentenfasern
IT1399468B1 (it) * 2010-04-16 2013-04-19 Tecnofilm Spa Polimeri e compound biodegradabili.
JP5403520B2 (ja) * 2010-05-25 2014-01-29 独立行政法人物質・材料研究機構 電界紡糸ファイバーマット複合体及びグルコースセンサ
EP2588653B1 (de) * 2010-07-02 2018-06-20 The Procter and Gamble Company Verfahren zur behandlung von textilen flächengebilden
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
JP5770280B2 (ja) * 2010-07-02 2015-08-26 ザ プロクター アンド ギャンブルカンパニー 非香料系活性剤を含むフィラメントの不織布ウェブ及びその作製方法
CA2803625C (en) * 2010-07-02 2016-04-05 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
RU2535040C2 (ru) 2010-07-02 2014-12-10 Дзе Проктер Энд Гэмбл Компани Способы доставки медицинского активного агента путем введения индивидуальных медицинских изделий, содержащих филамент
CN102971126B (zh) 2010-07-02 2016-03-23 宝洁公司 由非织造纤维网制备膜的方法
WO2012003367A2 (en) * 2010-07-02 2012-01-05 The Procter & Gamble Company Method for delivering an active agent
CA2803381C (en) 2010-07-02 2015-03-24 The Procter & Gamble Company Web material and method for making same
WO2012025582A2 (de) 2010-08-26 2012-03-01 Basf Se Verfahren zur herstellung hochkonzentrierter lösungen von selbstassemblierenden proteinen
CN101953801B (zh) * 2010-10-20 2012-07-04 重庆大学 可程序性控制给药的核/壳结构纳微粒多药给药系统的制备方法
US20120183861A1 (en) 2010-10-21 2012-07-19 Eastman Chemical Company Sulfopolyester binders
US9205089B2 (en) 2011-04-29 2015-12-08 Massachusetts Institute Of Technology Layer processing for pharmaceuticals
JP5801626B2 (ja) * 2011-06-30 2015-10-28 国立大学法人信州大学 複合ナノ繊維の製造方法
DE102011085511A1 (de) * 2011-10-31 2013-05-02 Siemens Medical Instruments Pte. Ltd. Membran zum Abdecken einer Öffnung in einem Hörgerät
JP5883271B2 (ja) * 2011-11-02 2016-03-09 Ｓｐｉｂｅｒ株式会社 人造ポリペプチド極細繊維の製造方法
US12440083B2 (en) 2012-01-04 2025-10-14 The Procter & Gamble Company Fibrous structures comprising particles and methods for making same
GB2498265B (en) * 2012-01-04 2015-04-08 Procter & Gamble Fibrous structures comprising particles and methods for making same
US10694917B2 (en) 2012-01-04 2020-06-30 The Procter & Gamble Company Fibrous structures comprising particles and methods for making same
US8906200B2 (en) 2012-01-31 2014-12-09 Eastman Chemical Company Processes to produce short cut microfibers
ES2933048T3 (es) * 2012-08-17 2023-01-31 Amsilk Gmbh Uso de polipéptidos de autoensamblaje como adhesivos tisulares
CN105246469A (zh) 2013-03-12 2016-01-13 活性纤维有限公司 纳米纤维和生物活性组合物及相关方法
US9617685B2 (en) 2013-04-19 2017-04-11 Eastman Chemical Company Process for making paper and nonwoven articles comprising synthetic microfiber binders
EP3041921B1 (de) 2013-09-06 2020-06-17 The Procter and Gamble Company Beutel mit wasserlöslichen faserigen wandmaterialien und verfahren zur herstellung davon
US9598802B2 (en) 2013-12-17 2017-03-21 Eastman Chemical Company Ultrafiltration process for producing a sulfopolyester concentrate
US9605126B2 (en) 2013-12-17 2017-03-28 Eastman Chemical Company Ultrafiltration process for the recovery of concentrated sulfopolyester dispersion
CA2943415C (en) * 2014-04-22 2018-09-04 The Procter & Gamble Company Filaments and fibrous structures employing same
WO2015179461A1 (en) 2014-05-20 2015-11-26 Massachusetts Institute Of Technology Plasticity induced bonding
KR101929450B1 (ko) 2015-09-04 2018-12-14 주식회사 엘지화학 고흡수성 수지 섬유의 제조 방법
US11324704B2 (en) * 2016-03-07 2022-05-10 Osaka University Sustained drug release sheet for treating nerve injury
US11697905B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles that exhibit consumer acceptable article in-use properties
US11697904B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles that exhibit consumer acceptable article in-use properties
US11697906B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles and product-shipping assemblies for containing the same
WO2018140676A2 (en) 2017-01-27 2018-08-02 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
EP3624765A1 (de) 2017-05-16 2020-03-25 The Procter and Gamble Company Konditionierende haarpflegezusammensetzungen in form von löslichen festen strukturen
WO2019018905A1 (pt) * 2017-07-28 2019-01-31 Universidade Estadual De Campinas - Unicamp Processo de obtenção de membranas de nanofibras de alginato/peo mucoadesivas duplamente reticuladas, membranas de nanofibras e uso
WO2019147534A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
KR20200086739A (ko) 2018-01-26 2020-07-17 더 프록터 앤드 갬블 캄파니 효소를 포함하는 수용성 단위 용량 물품
WO2019147532A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
WO2019147523A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble articles and related processes
CN108338212B (zh) * 2018-02-05 2024-05-31 乌鲁木齐市格瑞德保鲜科技有限公司 一种保鲜层合物及其制备方法与应用
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US12234431B2 (en) 2018-10-03 2025-02-25 The Procter & Gamble Company Water-soluble unit dose articles comprising water-soluble fibrous structures and particles
CN113748195B (zh) 2019-01-28 2024-01-19 宝洁公司 可回收利用的、可再生的或可生物降解的包装
JP7513623B2 (ja) 2019-03-19 2024-07-09 ザ プロクター アンド ギャンブル カンパニー 布地上の悪臭を低減する方法
EP3712237A1 (de) 2019-03-19 2020-09-23 The Procter & Gamble Company Faserige wasserlösliche einmal-dosierartikel mit wasserlöslichen faserstrukturen
CN110344126A (zh) * 2019-06-18 2019-10-18 浙江理工大学 一种多孔醋酸纤维素微/纳米纤维膜的离心纺丝制备方法
JP7381613B2 (ja) 2019-06-28 2023-11-15 ザ プロクター アンド ギャンブル カンパニー アニオン性界面活性剤を含有する溶解性固体繊維性物品
EP4188554A1 (de) 2020-07-31 2023-06-07 The Procter & Gamble Company Wasserlöslicher faserbeutel mit perlen zur haarpflege
JP7605842B2 (ja) 2020-08-19 2024-12-24 ザ プロクター アンド ギャンブル カンパニー 直接添加マイクロカプセルを含有する可撓性多孔質溶解性固体シート物品及びそれを作製するための方法
CN113638061A (zh) * 2021-08-13 2021-11-12 上海交通大学 一种高效的超大量液槽池制备方法
CN117881380A (zh) 2021-08-30 2024-04-12 宝洁公司 包含第一聚合结构剂和第二聚合结构剂的可溶性固体结构

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032397A2 (en) * 2000-10-18 2002-04-25 Virginia Commonwealth University Intellectual Property Foundation Electroprocessing in drug delivery and cell encapsulation
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
WO2003099230A2 (en) * 2002-05-28 2003-12-04 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
WO2004000915A2 (en) * 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof
US20060240110A1 (en) * 2005-03-31 2006-10-26 Kiick Kristi L Multifunctional and biologically active matrices from multicomponent polymeric solutions
WO2007082936A1 (de) * 2006-01-20 2007-07-26 Basf Se Verwendung von amphiphilen selbstassemblierenden proteinen zur formulierung von schwer wasserlöslichen effektstoffen
WO2008101051A2 (en) * 2007-02-14 2008-08-21 Dow Global Technologies Inc. Polymer or oligomer fibers by solvent-free electrospinning

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4315609A1 (de) 1993-05-11 1994-11-17 Basf Ag Verfahren und Vorrichtung zur Herstellung von Fasern nach einem Zentrifugalspinnverfahren
DE4440858A1 (de) * 1994-11-15 1996-05-23 Basf Ag Biologisch abbaubare Polymere, Verfahren zu deren Herstellung sowie deren Verwendung zur Herstellung bioabbaubarer Formkörper
DE19505995A1 (de) 1995-02-21 1996-08-22 Degussa Verfahren zur Herstellung von Thietanonen
DE19600162A1 (de) * 1996-01-04 1997-07-10 Bayer Faser Gmbh Schmelzgesponnene, scheuerbeständige Monofile
AU1670997A (en) 1996-04-26 1997-11-19 Nippon Soda Co., Ltd. Novel benzene derivatives substituted by heterocycles and herbicides
CA2252543C (en) 1996-04-26 2003-01-14 Nippon Soda Co., Ltd. Benzene derivatives substituted by heterocycles and herbicides
AU1670797A (en) 1996-04-26 1997-11-19 Nippon Soda Co., Ltd. Benzene derivatives substituted by heterocycles and herbicides
DE10023456A1 (de) 1999-07-29 2001-02-01 Creavis Tech & Innovation Gmbh Meso- und Nanoröhren
EP1088918A1 (de) 1999-09-29 2001-04-04 Basf Corporation Hitzehärtbare/thermoplastische Fasern und Verfahren zu deren Herstellung
AU772830B2 (en) 2000-01-28 2004-05-06 Smithkline Beecham Corporation Electrospun pharmaceutical compositions
DE10036655A1 (de) 2000-07-26 2002-02-07 Basf Ag Kosmetische oder dermatologische Zubereitungen zur Vermeidung von Hautschädigungen durch Peroxide
AU2001288692A1 (en) * 2000-09-01 2002-03-13 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed fibrin-based matrices and tissues
JP2002284608A (ja) 2001-01-18 2002-10-03 Sumitomo Chem Co Ltd 殺虫剤および殺虫方法
JP2003026510A (ja) 2001-05-09 2003-01-29 Sumitomo Chem Co Ltd マロノニトリル化合物およびその有害生物防除用途
DE10133393B4 (de) 2001-07-13 2007-08-30 TransMIT Gesellschaft für Technologietransfer mbH Röhrchen mit Innendurchmessern im Nanometerbereich
US7309498B2 (en) * 2001-10-10 2007-12-18 Belenkaya Bronislava G Biodegradable absorbents and methods of preparation
AU2003206690A1 (en) 2002-01-18 2003-07-30 Basf Aktiengesellschaft Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides
CN100343233C (zh) 2002-07-17 2007-10-17 住友化学株式会社 丙二腈化合物及其用途
JP4457588B2 (ja) 2002-07-17 2010-04-28 住友化学株式会社 マロノニトリル化合物の用途
TW200410714A (en) 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
JP2006502135A (ja) * 2002-08-13 2006-01-19 メドトロニック・インコーポレーテッド 活性薬剤デリバリーの、システム、医学用装置、及び方法
BR0313964A (pt) 2002-08-29 2005-07-19 Sumitomo Chemical Co Composto de malononitrilo e emprego deste
KR100461760B1 (ko) 2002-11-29 2004-12-14 주식회사 효성 폴리우레탄 탄성사의 제조 방법
DE102004009887A1 (de) 2004-02-26 2005-07-21 Ticona Gmbh Verfahren zum elektrostatischen Verspinnen oder Versprühen von Polymeren
DE102005048939A1 (de) 2005-07-01 2007-01-11 Carl Freudenberg Kg Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung
EP1942728A1 (de) 2005-10-27 2008-07-16 Basf Se Agrochemische nanopartikuläre wirkstoffformulierungen
JP2010501738A (ja) * 2006-08-21 2010-01-21 ビーエーエスエフ ソシエタス・ヨーロピア コロイド分散液のエレクトロスピニングによるナノ繊維及びメソ繊維の製造方法
US20100015070A1 (en) * 2006-11-08 2010-01-21 Basf Se Use of natural, recombinant and synthetic resilins in cosmetics
WO2008155304A1 (de) * 2007-06-20 2008-12-24 Basf Se Synthetische repetitive proteine, deren herstellung und verwendung
US20100221519A1 (en) * 2007-07-18 2010-09-02 Basf Se Process for producing nano- and mesofibers by electrospinning colloidal dispersions comprising at least one essentially water-insoluble polymer
EP2224901A1 (de) * 2007-12-21 2010-09-08 Basf Se Anti-schuppen-zusammensetzungen mit peptiden

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032397A2 (en) * 2000-10-18 2002-04-25 Virginia Commonwealth University Intellectual Property Foundation Electroprocessing in drug delivery and cell encapsulation
WO2003099230A2 (en) * 2002-05-28 2003-12-04 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
WO2004000915A2 (en) * 2002-06-24 2003-12-31 Tufts University Silk biomaterials and methods of use thereof
US20030017208A1 (en) * 2002-07-19 2003-01-23 Francis Ignatious Electrospun pharmaceutical compositions
US20060240110A1 (en) * 2005-03-31 2006-10-26 Kiick Kristi L Multifunctional and biologically active matrices from multicomponent polymeric solutions
WO2007082936A1 (de) * 2006-01-20 2007-07-26 Basf Se Verwendung von amphiphilen selbstassemblierenden proteinen zur formulierung von schwer wasserlöslichen effektstoffen
WO2007082923A2 (de) * 2006-01-20 2007-07-26 Basf Se Verwendung von protein-microbeads in der kosmetik
WO2008101051A2 (en) * 2007-02-14 2008-08-21 Dow Global Technologies Inc. Polymer or oligomer fibers by solvent-free electrospinning

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BERGER J ET AL: "Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL LNKD- DOI:10.1016/S0939-6411(03)00161-9, vol. 57, no. 1, 1 January 2004 (2004-01-01), pages 19 - 34, XP004518749, ISSN: 0939-6411 *
J H. EXLER ET AL.: "Die amphiphilen Eigenschaften von Spinnenseidenproteinen sind entscheidend für ihr Verspinnen", ANGEW. CHEMIE, vol. 119, 1 January 2007 (2007-01-01) - 1 January 2007 (2007-01-01), Weinheim, pages 3629 - 3632, XP002592504, DOI: 10.1002/ange.200604718 *
JAYAKUMAR R ET AL: "Novel chitin and chitosan nanofibers in biomedical applications", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, vol. 28, no. 1, 1 January 2010 (2010-01-01), pages 142 - 150, XP026796009, ISSN: 0734-9750, [retrieved on 20091111] *
LIEBMANN B ET AL: "Formulation of poorly water-soluble substances using self-assembling spider silk protein", COLLOIDS AND SURFACES. A, PHYSICACHEMICAL AND ENGINEERING ASPECTS, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/J.COLSURFA.2008.04.005, vol. 331, no. 1-2, 12 April 2008 (2008-04-12), pages 126 - 132, XP025680788, ISSN: 0927-7757, [retrieved on 20080412] *

Also Published As

Publication number Publication date
JP2011530661A (ja) 2011-12-22
US20110129510A1 (en) 2011-06-02
CN102176905A (zh) 2011-09-07
WO2010015709A2 (de) 2010-02-11
EP2323635A2 (de) 2011-05-25

Similar Documents

Publication Publication Date Title
WO2010015709A3 (de) Wirkstoffhaltige fasernflächengebilde mit einstellbarer wirkstofffreisetzung, ihre anwendungen und verfahren zu ihrer herstellung
WO2010027678A3 (en) Medical devices having inorganic coatings for therapeutic agent delivery
WO2009113703A3 (en) Orally-disintegrating solid preparation
WO2009009627A3 (en) Endoprosthesis coating
WO2009142869A3 (en) Methods of forming structures supported by semiconductor substrates
WO2010021757A3 (en) Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
WO2011049309A3 (ko) 속효성과 지속성을 동시에 갖는 약제학적 조성물
WO2010125323A8 (en) Biocidal composition
WO2012003351A3 (en) Web material and method for making same
WO2009030919A3 (en) Bioactive nanocomposite material
WO2009064879A3 (en) Antimicrobial coatings for medical devices and methods for making and using them
WO2009158120A3 (en) Stabilized transdermal drug delivery system
WO2009059165A3 (en) Endoprosthesis coating
WO2011095813A3 (en) Prosthesis
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2007092583A3 (en) Functionalizing implantable devices with a poly (diol-co-citrate) polymer
WO2011031882A3 (en) Methods of manufacturing drug-loaded substrates
WO2010022053A3 (en) Fabrication of monolithic zones on porous scaffold
WO2008142129A3 (en) Partially degradable scaffolds for biomedical applications
WO2007117786A3 (en) A process for producing coated urea-formaldehyde polymers
EG25586A (en) Coated fertiliser with a controlled release of active ingredients, and method for the production thereof
WO2009052516A3 (en) Method of coating medical devices
WO2012012736A3 (en) Method of treating a viral infection dysfunction by disrupting an adenosine receptor pathway
WO2011077239A3 (en) Slow release pharmaceutical compositions of iloperidone
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980139772.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09781627

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2011521595

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2009781627

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13058033

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE